salut, voilà une proposition de correction, en attendant peut être mieux
Embryonic research
seems significant on two points : in the pharmacological fields and in
transplantation according to the "regenerating capacity". For Axel Kahn these two points are related
to cell nucleus reprogrammation, and then the production of
embryonic cells lineage stocks.
Thus, this research could help to fight against
genetic disease. A third
factor would be
important for Kahn:
inheritance. However Korean studies showed the difficulty in
obtaining cell lineage stocks. A better knowledge
about this
third factor may improve acquisition of cellular
lineages. Peschanski confirms and
would even like to optimize research. Doctor Stokjovic, received
British authorities agreements to study these points. For him, research will be long because
only allowed at the very beginning of cell lives. After six months of Korean research,
no confirmed result.